mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for S100A1
Gene summary
Basic gene Info.Gene symbolS100A1
Gene nameS100 calcium binding protein A1
SynonymsS100|S100-alpha|S100A
CytomapUCSC genome browser: 1q21
Type of geneprotein-coding
RefGenesNM_006271.1,
DescriptionS-100 protein alpha chainS-100 protein subunit alphaS100 alphaS100 calcium-binding protein A1S100 protein, alpha polypeptideprotein S100-A1
Modification date20141207
dbXrefs MIM : 176940
HGNC : HGNC
Ensembl : ENSG00000160678
HPRD : 01489
Vega : OTTHUMG00000037041
ProteinUniProt: P23297
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_S100A1
BioGPS: 6271
PathwayNCI Pathway Interaction Database: S100A1
KEGG: S100A1
REACTOME: S100A1
Pathway Commons: S100A1
ContextiHOP: S100A1
ligand binding site mutation search in PubMed: S100A1
UCL Cancer Institute: S100A1
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for S100A1

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
S20S20LBRCA1
E69,D67G68EHNSC1
E69,D67G68WLUAD1
E69D71NLUSC1
K28K28NUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for S100A1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
S20S20L0.41542895
K28K28N-0.77425667
E69D71N-0.37407158
E69G68E-0.34697361
D67G68E-0.34697361
D67G68W-0.32153137
E69G68W-0.32153137
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for S100A1 from PDB

Top
Differential gene expression and gene-gene network for S100A1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of S100A1 and the right PPI network was created from samples without mutations in the LBS of S100A1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for S100A1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0751895Vasospasm, Intracranial1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for S100A1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
ApprovedDB00768OlopatadineSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of S100A1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of S100A1
Multiple alignments for P23297 in multiple species
LBSAA sequence# speciesSpecies
D25SGKEGDKYKLS3Homo sapiens, Rattus norvegicus, Bos taurus
D25SGQEGDKYKLS1Mus musculus
D63VMKELDENGDG3Homo sapiens, Mus musculus, Bos taurus
D63IMKELDENGDG1Rattus norvegicus
D67LDENGDGEVDF4Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus
E23AHSGKEGDKYK3Homo sapiens, Rattus norvegicus, Bos taurus
E23AHSGQEGDKYK1Mus musculus
E33KLSKKELKELL2Homo sapiens, Bos taurus
E33KLSKKELKDLL2Mus musculus, Rattus norvegicus
E69ENGDGEVDFQE3Homo sapiens, Rattus norvegicus, Bos taurus
E69ENGDGEVDFKE1Mus musculus
E74EVDFQEYVVLV2Homo sapiens, Bos taurus
E74EVDFKEYVVLV1Mus musculus
E74EVDFQEFVVLV1Rattus norvegicus
G24HSGKEGDKYKL3Homo sapiens, Rattus norvegicus, Bos taurus
G24HSGQEGDKYKL1Mus musculus
H19NVFHAHSGKEG3Homo sapiens, Rattus norvegicus, Bos taurus
H19NVFHAHSGQEG1Mus musculus
K26GKEGDKYKLSK3Homo sapiens, Rattus norvegicus, Bos taurus
K26GQEGDKYKLSK1Mus musculus
K28EGDKYKLSKKE4Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus
L29GDKYKLSKKEL4Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus
N65KELDENGDGEV4Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus
S20VFHAHSGKEGD3Homo sapiens, Rattus norvegicus, Bos taurus
S20VFHAHSGQEGD1Mus musculus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas